Cellectis S.A. (EPA:ALCLS)

France · Delayed Price · Currency is EUR

3.105

+0.095 (3.16%)

Apr 2, 2026, 5:35 PM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Therapeutics	79.59M	49.22M	9.19M	25.72M	38.60M
Therapeutics Growth	61.72%	435.37%	-64.26%	-33.35%	-35.20%
Total	79.59M	49.22M	9.19M	25.72M	38.60M
Total Growth	61.72%	435.37%	-64.26%	-33.35%	-35.20%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
France	72.95M	41.51M	755.00K	19.17M	30.35M
France Growth	75.76%	5397.35%	-96.06%	-36.83%	-40.56%
Unallocated	6.64M	7.71M	8.44M	6.55M	8.25M
Unallocated Growth	-13.85%	-8.60%	28.77%	-20.57%	-3.02%
Total	79.59M	49.22M	9.19M	25.72M	38.60M
Total Growth	61.72%	435.37%	-64.26%	-33.35%	-35.20%

Source: S&P Global Market Intelligence.